Top

Cardiovascular Toxicology

Published in:

01-06-2012

What are the Values of Using QTc and N-Terminal Fragment of B-Type Natriuretic Peptide as Markers for Early Detection of Acute Antipsychotic Drugs-Induced Cardiotoxicity?

Author: Hossein Sanaei-Zadeh

Published in: Cardiovascular Toxicology | Issue 2/2012

Excerpt

Dear Editor, …

Khalaf, M. A., Abdelrahman, T. M., & Abbas, M. F. (2011). Values of using QTc and N-terminal fragment of B-type natriuretic peptide as markers for early detection of acute antipsychotic drugs-induced cardiotoxicity. Cardiovascular Toxicology, 11(1), 10–17.PubMedCrossRef

Chan, D., & Ng, L. L. (2010). Biomarkers in acute myocardial infarction. BMC Medicine, 8, 34.PubMedCrossRef

Thejus, J., & Francis, J. (2009). N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing and Electrophysiology Journal, 9(1), 1–4.PubMed

Rademaker, M. T., & Richards, A. M. (2005). Cardiac natriuretic peptides for cardiac health. Clinical Science (London), 108(1), 23–36.CrossRef

Richards, A. M., & Frampton, C. M. (2005). N-terminal-Pro-B–type natriuretic peptide: Universal marker of cardiovascular risk? Circulation, 112, 9–11.PubMedCrossRef

Kropp, S., Tountopoulou, A., Schneider, U., & Lichtinghagen, R. (2005). N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Annals of General Psychiatry, 4, 10.PubMedCrossRef

Chan, A., Isbister, G. K., Kirkpatrick, C. M., & Dufful, S. B. (2007). Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram. The Quarterly Journal of Medicine, 100(10), 609–615.CrossRef

Title: What are the Values of Using QTc and N-Terminal Fragment of B-Type Natriuretic Peptide as Markers for Early Detection of Acute Antipsychotic Drugs-Induced Cardiotoxicity?
Author: Hossein Sanaei-Zadeh
Publication date: 01-06-2012
Publisher: Humana Press Inc
Published in: Cardiovascular Toxicology / Issue 2/2012
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-011-9151-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

What are the Values of Using QTc and N-Terminal Fragment of B-Type Natriuretic Peptide as Markers for Early Detection of Acute Antipsychotic Drugs-Induced Cardiotoxicity?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2012

Prediction of Anthracycline Cardiotoxicity after Chemotherapy by Biomarkers Kinetic Analysis

A Case of Caffeine-Induced Coronary Artery Vasospasm of a 17-Year-Old Male

Is Serum S100B Protein a Biomarker for Amitriptyline-Induced Cardiovascular Toxic Effects?

Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart

Comparing Effects of Lacidipine, Ramipril, and Valsartan Against Experimentally Induced Myocardial Infarcted Rats

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page